UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 49

Sortiert nach

Updated Analysis of SWOG-Directed Intergroup Study 0116: A Phase III Trial of Adjuvant Radiochemotherapy Versus Observation After Curative Gastric Cancer Resection

Journal of clinical oncology, 2012-07, Vol.30 (19), p.2327-2333

2012

Volltextzugriff (PDF)

Future Directions in the Treatment of Neuroendocrine Tumors: Consensus Report of the National Cancer Institute Neuroendocrine Tumor Clinical Trials Planning Meeting

Journal of clinical oncology, 2011-03, Vol.29 (7), p.934-943

2011

Volltextzugriff (PDF)

American Society of Clinical Oncology Recommendations on Adjuvant Chemotherapy for Stage II Colon Cancer

Journal of clinical oncology, 2004-08, Vol.22 (16), p.3408-3419

2004

Volltextzugriff (PDF)

Disease-Free Survival Versus Overall Survival As a Primary End Point for Adjuvant Colon Cancer Studies: Individual Patient Data From 20,898 Patients on 18 Randomized Trials

Journal of clinical oncology, 2005-12, Vol.23 (34), p.8664-8670

2005

Volltextzugriff (PDF)

Pooled Analysis of Fluorouracil-Based Adjuvant Therapy for Stage II and III Colon Cancer: Who Benefits and by How Much?

Journal of clinical oncology, 2004-05, Vol.22 (10), p.1797-1806

2004

Volltextzugriff (PDF)

Survival Following Recurrence in Stage II and III Colon Cancer: Findings From the ACCENT Data Set

Journal of clinical oncology, 2008-05, Vol.26 (14), p.2336-2341

2008

Volltextzugriff (PDF)

Comparison of Outcomes After Fluorouracil-Based Adjuvant Therapy for Stages II and III Colon Cancer Between 1978 to 1995 and 1996 to 2007: Evidence of Stage Migration From the ACCENT Database

Journal of clinical oncology, 2013-10, Vol.31 (29), p.3656-3663

2013

Volltextzugriff (PDF)

Phase III Study of Fluorouracil, Leucovorin, and Levamisole in High-Risk Stage II and III Colon Cancer: Final Report of Intergroup 0089

Journal of clinical oncology, 2005-12, Vol.23 (34), p.8671-8678

2005

Volltextzugriff (PDF)

End Points for Colon Cancer Adjuvant Trials: Observations and Recommendations Based on Individual Patient Data From 20,898 Patients Enrolled Onto 18 Randomized Trials From the ACCENT Group

Journal of clinical oncology, 2007-10, Vol.25 (29), p.4569-4574

2007

Volltextzugriff (PDF)

Potential Regional Differences for the Tolerability Profiles of Fluoropyrimidines

Journal of clinical oncology, 2008-05, Vol.26 (13), p.2118-2123

2008

Volltextzugriff (PDF)

A Pooled Analysis of Adjuvant Chemotherapy for Resected Colon Cancer in Elderly Patients

The New England journal of medicine, 2001-10, Vol.345 (15), p.1091-1097

2001

Volltextzugriff (PDF)

Phase III Trial of Capecitabine Plus Oxaliplatin As Adjuvant Therapy for Stage III Colon Cancer: A Planned Safety Analysis in 1,864 Patients

Journal of clinical oncology, 2007-01, Vol.25 (1), p.102-109

2007

Volltextzugriff (PDF)

Molecular Predictors of Survival after Adjuvant Chemotherapy for Colon Cancer

The New England journal of medicine, 2001-04, Vol.344 (16), p.1196-1206

2001

Volltextzugriff (PDF)

Benefit of Oxaliplatin in Stage III Colon Cancer According to IDEA Risk Groups: Findings from the ACCENT Database of 4934 Patients

Clinical colorectal cancer, 2021-06, Vol.20 (2), p.130-136

2021

Volltextzugriff (PDF)

Accuracy of determining nodal negativity in colorectal cancer on the basis of the number of nodes retrieved on resection

Annals of surgical oncology, 2003-04, Vol.10 (3), p.213-218

2003

Volltextzugriff (PDF)

Consensus report of the International Society of Gastrointestinal Oncology on therapeutic progress in advanced pancreatic cancer

Cancer, 2006-08, Vol.107 (4), p.676-685

2006

Volltextzugriff (PDF)

Surveillance for second primary colorectal cancer after adjuvant chemotherapy: an analysis of Intergroup 0089

Annals of internal medicine, 2002-02, Vol.136 (4), p.261

2002

Volltextzugriff (PDF)

Combined chemoradiotherapy vs. radiotherapy alone for early stage squamous cell carcinoma of the esophagus: a study of the eastern cooperative oncology group

International journal of radiation oncology, biology, physics, 1998-09, Vol.42 (2), p.269-276

1998

Volltextzugriff (PDF)

A Phase I Trial of the Dual Farnesyltransferase and Geranylgeranyltransferase Inhibitor L-778,123 and Radiotherapy for Locally Advanced Pancreatic Cancer

Clinical cancer research, 2004-08, Vol.10 (16), p.5447-5454

2004

Volltextzugriff (PDF)

The national practice for patients receiving radiation therapy for carcinoma of the esophagus: Results of the 1996–1999 Patterns of Care Study

International journal of radiation oncology, biology, physics, 2003-07, Vol.56 (4), p.981-987

2003

Volltextzugriff (PDF)

Outcome Results of the 1996-1999 Patterns of Care Survey of the National Practice for Patients Receiving Radiation Therapy for Carcinoma of the Esophagus

Journal of clinical oncology, 2005-04, Vol.23 (10), p.2325-2331

2005

Volltextzugriff (PDF)

Long term survival after pancreatic resection for pancreatic adenocarcinoma

The American journal of gastroenterology, 2001-09, Vol.96 (9), p.2609-2615

2001

Volltextzugriff (PDF)

Priorities in Colorectal Cancer Research: Recommendations From the Gastrointestinal Scientific Leadership Council of the Coalition of Cancer Cooperative Groups

Journal of clinical oncology, 2007-06, Vol.25 (16), p.2313-2321

2007

Volltextzugriff (PDF)

Levamisole and Fluorouracil for Adjuvant Therapy of Resected Colon Carcinoma

The New England journal of medicine, 1990-02, Vol.322 (6), p.352-358

1990

Volltextzugriff (PDF)

New perspectives in the management of pancreas cancer

Seminars in oncology, 2003-08, Vol.30 (4 Suppl 11), p.3-10

Haller, Daniel G

2003

Volltextzugriff (PDF)

1 – 25 von 49

Suche als RSS-Feed

Aktive Filter

SpracheJapanisch

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(49)
Mit Volltextzugriff
(44)

Publikationsform

Artikel
(49)

Sprache

Englisch
(49)

Erscheinungsjahr

n.n

Thema

Science & Technology
(48)
Humans
(44)
Life Sciences & Biomedicine
(43)
Oncology
(31)
Female
(30)
Biological And Medical Sciences
(29)
Male
(28)
Medical Sciences
(27)
Middle Aged
(22)
Aged
(19)
Tumors
(18)
Gastroenterology. Liver. Pancreas. Abdomen
(16)
Treatment Outcome
(15)
Adult
(14)
Stomach. Duodenum. Small Intestine. Colon. Rectum. Anus
(14)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(13)
Fluorouracil - Administration & Dosage
(12)
Neoplasm Staging
(12)
Chemotherapy, Adjuvant
(11)
Colonic Neoplasms - Drug Therapy
(11)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Updated Analysis of SWOG-Directed Intergroup Study 0116: A Phase III Trial of Adjuvant Radiochemotherapy Versus Observation After Curative Gastric Cancer Resection

Future Directions in the Treatment of Neuroendocrine Tumors: Consensus Report of the National Cancer Institute Neuroendocrine Tumor Clinical Trials Planning Meeting

American Society of Clinical Oncology Recommendations on Adjuvant Chemotherapy for Stage II Colon Cancer

Disease-Free Survival Versus Overall Survival As a Primary End Point for Adjuvant Colon Cancer Studies: Individual Patient Data From 20,898 Patients on 18 Randomized Trials

Pooled Analysis of Fluorouracil-Based Adjuvant Therapy for Stage II and III Colon Cancer: Who Benefits and by How Much?

Survival Following Recurrence in Stage II and III Colon Cancer: Findings From the ACCENT Data Set

Comparison of Outcomes After Fluorouracil-Based Adjuvant Therapy for Stages II and III Colon Cancer Between 1978 to 1995 and 1996 to 2007: Evidence of Stage Migration From the ACCENT Database

Phase III Study of Fluorouracil, Leucovorin, and Levamisole in High-Risk Stage II and III Colon Cancer: Final Report of Intergroup 0089

End Points for Colon Cancer Adjuvant Trials: Observations and Recommendations Based on Individual Patient Data From 20,898 Patients Enrolled Onto 18 Randomized Trials From the ACCENT Group

Potential Regional Differences for the Tolerability Profiles of Fluoropyrimidines

A Pooled Analysis of Adjuvant Chemotherapy for Resected Colon Cancer in Elderly Patients

Phase III Trial of Capecitabine Plus Oxaliplatin As Adjuvant Therapy for Stage III Colon Cancer: A Planned Safety Analysis in 1,864 Patients

Molecular Predictors of Survival after Adjuvant Chemotherapy for Colon Cancer

Benefit of Oxaliplatin in Stage III Colon Cancer According to IDEA Risk Groups: Findings from the ACCENT Database of 4934 Patients

Accuracy of determining nodal negativity in colorectal cancer on the basis of the number of nodes retrieved on resection

Consensus report of the International Society of Gastrointestinal Oncology on therapeutic progress in advanced pancreatic cancer

Surveillance for second primary colorectal cancer after adjuvant chemotherapy: an analysis of Intergroup 0089

Combined chemoradiotherapy vs. radiotherapy alone for early stage squamous cell carcinoma of the esophagus: a study of the eastern cooperative oncology group

A Phase I Trial of the Dual Farnesyltransferase and Geranylgeranyltransferase Inhibitor L-778,123 and Radiotherapy for Locally Advanced Pancreatic Cancer

The national practice for patients receiving radiation therapy for carcinoma of the esophagus: Results of the 1996–1999 Patterns of Care Study

Outcome Results of the 1996-1999 Patterns of Care Survey of the National Practice for Patients Receiving Radiation Therapy for Carcinoma of the Esophagus

Long term survival after pancreatic resection for pancreatic adenocarcinoma

Priorities in Colorectal Cancer Research: Recommendations From the Gastrointestinal Scientific Leadership Council of the Coalition of Cancer Cooperative Groups

Levamisole and Fluorouracil for Adjuvant Therapy of Resected Colon Carcinoma

New perspectives in the management of pancreas cancer

Aktive Filter

Suchergebnisse filtern